BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12876796)

  • 21. Ribosome engineering and secondary metabolite production.
    Ochi K; Okamoto S; Tozawa Y; Inaoka T; Hosaka T; Xu J; Kurosawa K
    Adv Appl Microbiol; 2004; 56():155-84. PubMed ID: 15566979
    [No Abstract]   [Full Text] [Related]  

  • 22. An Efficient Markerless Deletion System Suitable for the Industrial Strains of
    Dong J; Wei J; Li H; Zhao S; Guan W
    J Microbiol Biotechnol; 2021 Dec; 31(12):1722-1731. PubMed ID: 34489377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Search for antibiotic antimetabolites].
    Gauze GF
    Antibiotiki; 1976 Jan; 21(1):3-5. PubMed ID: 776066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Finetuning pristinamycin synthesis in streptomycetes.
    Hopwood D
    Nat Biotechnol; 1997 Apr; 15(4):321. PubMed ID: 9094127
    [No Abstract]   [Full Text] [Related]  

  • 25. Heterologous expression of tylosin polyketide synthase and production of a hybrid bioactive macrolide in Streptomyces venezuelae.
    Jung WS; Lee SK; Hong JS; Park SR; Jeong SJ; Han AR; Sohng JK; Kim BG; Choi CY; Sherman DH; Yoon YJ
    Appl Microbiol Biotechnol; 2006 Oct; 72(4):763-9. PubMed ID: 16493552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy.
    Singh SB; Zink DL; Huber J; Genilloud O; Salazar O; Diez MT; Basilio A; Vicente F; Byrne KM
    Org Lett; 2006 Nov; 8(24):5449-52. PubMed ID: 17107044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering a regulatory region of jadomycin gene cluster to improve jadomycin B production in Streptomyces venezuelae.
    Zheng JT; Wang SL; Yang KQ
    Appl Microbiol Biotechnol; 2007 Sep; 76(4):883-8. PubMed ID: 17653711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of linear plasmids from lankacidin-producing Streptomyces species.
    Kinashi H; Mori E; Hatani A; Nimi O
    J Antibiot (Tokyo); 1994 Dec; 47(12):1447-55. PubMed ID: 7844039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The All-Union methodological seminar on "Cellular engineering of antibiotic producers"].
    Sazykin IuO
    Antibiot Khimioter; 1988 Mar; 33(3):163-4. PubMed ID: 3163913
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemistry: uncharted route for antibiotics.
    Quinn JP
    Nature; 2007 Jul; 448(7152):415-6. PubMed ID: 17653175
    [No Abstract]   [Full Text] [Related]  

  • 31. New 24-membered macrolides SPA-6952A and B produced by Streptomyces sp.
    Hosotani N; Kumagai K; Nakagawa H; Shimatani T; Saji I
    J Antibiot (Tokyo); 2005 Jun; 58(6):409-11. PubMed ID: 16156518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved antibiotic production and silent gene activation in Streptomyces diastatochromogenes by ribosome engineering.
    Shentu X; Liu N; Tang G; Tanaka Y; Ochi K; Xu J; Yu X
    J Antibiot (Tokyo); 2016 May; 69(5):406-10. PubMed ID: 26648118
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic perturbation to enhance polyketide and nonribosomal peptide antibiotic production using triclosan and ribosome-targeting drugs.
    Tanaka Y; Izawa M; Hiraga Y; Misaki Y; Watanabe T; Ochi K
    Appl Microbiol Biotechnol; 2017 Jun; 101(11):4417-4431. PubMed ID: 28293709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting the genetic potential of polyketide producing streptomycetes.
    Weber T; Welzel K; Pelzer S; Vente A; Wohlleben W
    J Biotechnol; 2003 Dec; 106(2-3):221-32. PubMed ID: 14651864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioconversion of 12-, 14-, and 16-membered ring aglycones to glycosylated macrolides in an engineered strain of Streptomyces venezuelae.
    Jung WS; Han AR; Hong JS; Park SR; Choi CY; Park JW; Yoon YJ
    Appl Microbiol Biotechnol; 2007 Oct; 76(6):1373-81. PubMed ID: 17665193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of the snorA gene in nogalamycin biosynthesis by strain Streptomyces nogalater Lv65 ].
    Klimyshin DO; Gren' TP; Fedorenko VO
    Mikrobiologiia; 2011; 80(4):490-5. PubMed ID: 22073550
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolution of Streptomyces pristinaespiralis for resistance and production of pristinamycin by genome shuffling.
    Xu B; Jin Z; Wang H; Jin Q; Jin X; Cen P
    Appl Microbiol Biotechnol; 2008 Aug; 80(2):261-7. PubMed ID: 18542945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthetic engineering of natural products for lead optimization and development.
    Wilkinson B; Moss SJ
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):748-56. PubMed ID: 16312150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous culture of immobilized streptomyces cells for kasugamycin production.
    Kim CJ; Chang YK; Chun GT; Jeong YH; Lee SJ
    Biotechnol Prog; 2001; 17(3):453-61. PubMed ID: 11386865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in streptothricin antibiotics - A review].
    Li J; Wang M; Chen Y
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):363-72. PubMed ID: 27382780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.